Frontiers | Evidence of compensatory neural hyperactivity in a subgroup of breast cancer survivors treated with chemotherapy and its association with brain aging
1 Department of Comparative Medicine, The University of Texas MD Anderson Cancer Center, Bastrop, TX, United States 2 Division of Adult Health, School of Nursing, University of Texas at Austin, Austin, TX, United States 3 Department of Medical Oncology, Stanford University School of Medicine, Palo Alto, CA, United States Introduction: Chemotherapy-related cognitive impairment (CRCI) remains poorly understood in terms of the mechanisms of cognitive decline. Neural hyperactivity has been reported on
